Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis

doi:10.3748/wjg.v10.i10.1409

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2574)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

234

HTML

2160

Figures (1-8)

180

Sum=2574

May 15, 2004 (publication date) through Jun 29, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. May 15, 2004; 10(10): 1409-1414
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1409

Full Size Figure Download Figure

Figure 2 Western blot analysis of expressed fusion protein by AdhENDO-VEGI₁₅₁ with polyclonal antibody against VEGI₁₅₁. Lane 1: protein marker; lane 2: 293 cell; lane 3: ECV304 cell; lane 4: HepG2 cell; lane 5: L929 cell.

Citation: Pan X, Wang Y, Zhang M, Pan W, Qi ZT, Cao GW. Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. World J Gastroenterol 2004; 10(10): 1409-1414
URL: https://www.wjgnet.com/1007-9327/full/v10/i10/1409.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i10.1409